Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.71 CHF
15.09 M CHF
48.95 M CHF
17.52 M
About Newron Pharmaceuticals S.p.A.
Sector
Industry
CEO
Stefan Weber
Website
Headquarters
Bresso
Founded
2002
ISIN
IT0004147952
FIGI
BBG000QXX5D6
Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focuses on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago (safinamide), Evenamide (NW-3509) and Ralfinamide. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NWRN is 9.51 CHF — it has increased by 5.36% in the past 24 hours. Watch Newron Pharmaceuticals S.p.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Newron Pharmaceuticals S.p.A. stocks are traded under the ticker NWRN.
NWRN stock has fallen by −0.11% compared to the previous week, the month change is a 29.71% rise, over the last year Newron Pharmaceuticals S.p.A. has showed a 17.41% increase.
We've gathered analysts' opinions on Newron Pharmaceuticals S.p.A. future price: according to them, NWRN price has a max estimate of 11.49 CHF and a min estimate of 11.49 CHF. Watch NWRN chart and read a more detailed Newron Pharmaceuticals S.p.A. stock forecast: see what analysts think of Newron Pharmaceuticals S.p.A. and suggest that you do with its stocks.
NWRN reached its all-time high on Jul 6, 2007 with the price of 80.25 CHF, and its all-time low was 0.90 CHF and was reached on May 4, 2020. View more price dynamics on NWRN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NWRN stock is 12.68% volatile and has beta coefficient of 2.00. Track Newron Pharmaceuticals S.p.A. stock price on the chart and check out the list of the most volatile stocks — is Newron Pharmaceuticals S.p.A. there?
Today Newron Pharmaceuticals S.p.A. has the market capitalization of 178.65 M, it has decreased by −1.28% over the last week.
Yes, you can track Newron Pharmaceuticals S.p.A. financials in yearly and quarterly reports right on TradingView.
Newron Pharmaceuticals S.p.A. is going to release the next earnings report on Mar 17, 2026. Keep track of upcoming events with our Earnings Calendar.
Newron Pharmaceuticals S.p.A. revenue for the last half-year amounts to 11.12 M CHF, despite the estimated figure of 8.32 M CHF. In the next half-year revenue is expected to reach 3.64 M CHF.
NWRN net income for the last half-year is 23.97 M CHF, while the previous report showed −9.19 M CHF of net income which accounts for 360.86% change. Track more Newron Pharmaceuticals S.p.A. financial stats to get the full picture.
No, NWRN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Newron Pharmaceuticals S.p.A. EBITDA is 24.75 M CHF, and current EBITDA margin is 51.30%. See more stats in Newron Pharmaceuticals S.p.A. financial statements.
Like other stocks, NWRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Newron Pharmaceuticals S.p.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Newron Pharmaceuticals S.p.A. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Newron Pharmaceuticals S.p.A. stock shows the buy signal. See more of Newron Pharmaceuticals S.p.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.